These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11459455)

  • 21. Diabetes insipidus in uricase-deficient mice: a model for evaluating therapy with poly(ethylene glycol)-modified uricase.
    Kelly SJ; Delnomdedieu M; Oliverio MI; Williams LD; Saifer MGP; Sherman MR; Coffman TM; Johnson GA; Hershfield MS
    J Am Soc Nephrol; 2001 May; 12(5):1001-1009. PubMed ID: 11316859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification with polysialic acid-PEG copolymer as a new method for improving the therapeutic efficacy of proteins.
    Wu J; Lu S; Zheng Z; Zhu L; Zhan X
    Prep Biochem Biotechnol; 2016 Nov; 46(8):788-797. PubMed ID: 26829568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and characterization of poly(ethylene glycol)-poly(D,L-lactide-co-glycolide) poly(ethylene glycol) tri-block co-polymers modified with collagen: a model surface suitable for cell interaction.
    Porjazoska A; Yilmaz OK; Baysal K; Cvetkovska M; Sirvanci S; Ercan F; Baysal BM
    J Biomater Sci Polym Ed; 2006; 17(3):323-40. PubMed ID: 16689018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of plasma urate levels in the cockerel with polyethylene glycol-uricase.
    Abuchowski A; Karp D; Davis FF
    J Pharmacol Exp Ther; 1981 Nov; 219(2):352-4. PubMed ID: 7288624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New synthetic amphiphilic polymers for steric protection of liposomes in vivo.
    Torchilin VP; Trubetskoy VS; Whiteman KR; Caliceti P; Ferruti P; Veronese FM
    J Pharm Sci; 1995 Sep; 84(9):1049-53. PubMed ID: 8537880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly(ethylene glycol)-avidin bioconjugates: suitable candidates for tumor pretargeting.
    Caliceti P; Chinol M; Roldo M; Veronese FM; Semenzato A; Salmaso S; Paganelli G
    J Control Release; 2002 Sep; 83(1):97-108. PubMed ID: 12220842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(ethylene glycol)-doxorubicin conjugates containing beta-lactamase-sensitive linkers.
    Senter PD; Svensson HP; Schreiber GJ; Rodriguez JL; Vrudhula VM
    Bioconjug Chem; 1995; 6(4):389-94. PubMed ID: 7578358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polypeptides with High Zwitterion Density for Safe and Effective Therapeutics.
    Zhang P; Jain P; Tsao C; Yuan Z; Li W; Li B; Wu K; Hung HC; Lin X; Jiang S
    Angew Chem Int Ed Engl; 2018 Jun; 57(26):7743-7747. PubMed ID: 29707870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biopharmaceutical characterisation of new poly(hydroxyethylaspartamide) copolymers as drug carriers.
    Caliceti P; Quarta SM; Veronese FM; Cavallaro G; Pedone E; Giammona G
    Biochim Biophys Acta; 2001 Oct; 1528(2-3):177-86. PubMed ID: 11687305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revealing the Immunogenic Risk of Polymers.
    Li B; Yuan Z; Hung HC; Ma J; Jain P; Tsao C; Xie J; Zhang P; Lin X; Wu K; Jiang S
    Angew Chem Int Ed Engl; 2018 Oct; 57(42):13873-13876. PubMed ID: 30156051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescently labeled branched polymers and thermal responsive nanoparticles for live cell imaging.
    Di Zhou ; Ma Y; Poot AA; Dijkstra PJ; Feijen J
    Macromol Biosci; 2012 Apr; 12(4):465-74. PubMed ID: 22496042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-induced release of glycosylpoly(ethylene glycol) insulin bound to a soluble conjugate of concanavalin A.
    Liu F; Song SC; Mix D; Baudys M; Kim SW
    Bioconjug Chem; 1997; 8(5):664-72. PubMed ID: 9327129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microwave-assisted synthesis of poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) tri-block co-polymers and use as matrices for sustained delivery of ibuprofen taken as model drug.
    Yu Z; Liu L
    J Biomater Sci Polym Ed; 2005; 16(8):957-71. PubMed ID: 16128231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of PEG conjugation on insulin properties.
    Hinds KD; Kim SW
    Adv Drug Deliv Rev; 2002 Jun; 54(4):505-30. PubMed ID: 12052712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and antigenicity of soluble cross-linked enzyme/albumin polymers: Advantages for enzyme therapy.
    Remy MH; Poznansky MJ
    Lancet; 1978 Jul; 2(8080):68-70. PubMed ID: 78296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monocyte/macrophage interactions with base and linear- and star-like PEG-modified PEG-poly(acrylic acid) co-polymers.
    Wagner VE; Bryers JD
    J Biomed Mater Res A; 2003 Jul; 66(1):62-78. PubMed ID: 12833432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and characterization of poly(ethylene glycol)-insulin conjugates.
    Hinds K; Koh JJ; Joss L; Liu F; Baudys M; Kim SW
    Bioconjug Chem; 2000; 11(2):195-201. PubMed ID: 10725096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of large aggregated uricases and PEG diol on accelerated blood clearance of PEGylated canine uricase.
    Zhang C; Fan K; Ma X; Wei D
    PLoS One; 2012; 7(6):e39659. PubMed ID: 22745806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative immunology of mammalian uricase using anti-hog liver uricase.
    Htay HH; Sato K; Tamaki K; Tsutsumi H; Katsumata Y
    Comp Biochem Physiol B; 1989; 92(3):583-6. PubMed ID: 2495886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PEGylation enhancement of pH stability of uricase via inhibitive tetramer dissociation.
    Tian H; Guo Y; Gao X; Yao W
    J Pharm Pharmacol; 2013 Jan; 65(1):53-63. PubMed ID: 23215688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.